A Comprehensive Target Panel Allows to Extend the Genetic Spectrum of Neuroendocrine Tumors
Our study demonstrates that utilizing broad TGP in examining patients with various functioning NETs facilitates the identification of new germinal variants in genes that may contribute to the diseases. The verification of revealed findings requires research in vaster sample.
Authors
- Anna Aleksandrovna Kostareva (ORCID: https://orcid.org/0000-0002-9349-6257)
- Elena Grineva (ORCID: https://orcid.org/0000-0003-0042-7680)
- Yulia Fomicheva
- Pavel Ryazanov (ORCID: https://orcid.org/0000-0003-3684-8612)
- Е. Н. Кравчук (ORCID: https://orcid.org/0000-0003-3124-1512)
- Polina Sokolnikova (ORCID: https://orcid.org/0000-0001-7833-7840)
- Т. Л. Каронова (ORCID: https://orcid.org/0000-0002-1547-0123)
- A. A. Kozyreva (ORCID: https://orcid.org/0000-0003-0656-7967)
- Uliana Tsoy
- L.S. Aramisova Aramisova
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Federal Almazov North-West Medical Research Centre (RU)
Publication Details
- Journal
- Neuroendocrinology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1159/000542223
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Ministry of Science and Higher Education of the Russian Federation